胆红素和有毒胆汁酸在危急病患者胆固醇性肝功能障碍和吸附剂应用中的相关性
Caroline Gräfe1, Helen Graf2, Vassilissa Wustrow2
1Department of Anesthesiology, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany. caroline.graefe@med.uni-muenchen.de.
Scientific reports
|September 18, 2024
概括
在重症患者中,胆红素水平与有毒胆酸 (TBA) 相相关. 在CytoSorb治疗期间,比利鲁可以作为TBA减少的替代标记物,在六小时内显著消除.
科学领域:
- 关键护理医学 关键护理医学
- 肝病学 肝病学是一种肝病学.
- 生物化学 生物化学
背景情况:
- 患有胆固醇性肝功能障碍的重症患者通常具有升高的胆红素和有毒胆酸 (TBAs).
- TBAs可能会导致严重的器官损伤,但它们的直接监测不如 bilirubin 常见.
- 胆红素和TBA之间的相关性是合理的,但缺乏足够的数据.
研究的目的:
- 在重症患者中研究 bilirubin 和 TBA 度之间的相关性.
- 评估比利鲁宾是否可以作为在CytoSorb (CS) 治疗期间TBA减少的替代标记物.
- 评估CS在降低胆红素和TBAs中的有效性.
主要方法:
- 赛托-SOLVE研究招募了16名患有胆固醇性肝功能障碍和胆红素升高 (>10 mg/dl) 的危急病患者.
- 患者接受了连续的替代疗法和CytoSorb (CS) 应用.
- 胆红素和TBA度在基线,6小时和12小时被测量. 计算了相对减少 (RR).
主要成果:
- 在所有时间点 (r=0.64到0.85) 观察到胆红素和TBA度之间存在中等到高的相关性.
- 在6小时内,CytoSorb的应用导致TBA (中位RR39.8%) 和胆红素 (中位RR26.1%) 显著减少.
- 在CS应用后6至12小时之间没有观察到进一步显著的减少.
结论:
- 胆固醇性肝功能障碍患者的胆固醇和TBA水平之间存在显著的相关性.
- 胆红素是一种适合的替代参数,用于监测在CytoSorb治疗期间的TBA消除.
- 在应用后的前六小时内,CytoSorb在重症患者中有效降低了胆红素和TBAs.
相关概念视频
Hepatic Drug Excretion: Influencing Factors
98
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
98
Diseases of the Liver and Gallbladder
486
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
486
Hepatic Drug Excretion: Enterohepatic Cycling
1.2K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.2K
Prevention of Further Absorption of Poison
795
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
795
Chronic Bowel Disorders: Introduction
408
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
408
Hepatic Drug Clearance: Role of Transporters
44
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
44


